Punctal Plug Drug Delivery System
The PPDS is compatible with different types of molecules and can potentially be used to address a range of ocular diseases and conditions.
Two formulations have been taken into clinical trials – latanoprost for glaucoma and olopatadine for allergy relief - and we have an additional glaucoma agent ready to be taken into trials. Also, an NSAID has successfully been formulated and tested in pre-clinical elution studies. In addition, proof of concept studies have been conducted and pre-clinical data has been collected on molecules for dry eye and an anti-inflammatory.